Will Royalty Pharma (RPRX) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Royalty Pharma (RPRX) , which belongs to the Zacks Financial - Miscellaneous Services industry, could be a great candidate to consider. For the most recent quarter, Royalty Pharma was expected to post earnings of $0.96 per share, but it reported $0.98 per share instead, representing a surprise of 2.08%. For the previous quarter, the consensus estimate ...